KNSA: Kiniksa Pharmaceuticals Ltd Sotuvga nisbatan narx
GURU.Markets dinamik grafigidagi P/S biznes baholashi kamyob yurak-qon tomir patologiyalarini davolash ekotizimini aks ettiradi, bunda 4.90 qiymati ushbu darajani xarakterlaydi. Kiniksa Pharmaceuticals (KNSA) biotexnologiya institutlari bilan hamkorlik orqali immun yetishmovchiliklari uchun terapiyalarni ishlab chiqmoqda. Yallig'lanishli yurak kasalliklari nishasidagi kuchli patentlar yuqori marjalarni va bozorda bevosita ekvivalentlarning yo'qligini ta'minlaydi.
kiniksa.com (KNSA) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Kiniksa Pharmaceuticals|KNSA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti kiniksa.com|KNSA - Kompaniya qarzlari|Balans kapitallashuviga qarzlar Kiniksa|KNSA - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Kiniksa|Tezkor likvidlik koeffitsiyenti kiniksa.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
KNSA - Sof daromad|Kutilayotgan sof daromad Kiniksa Pharmaceuticals|KNSA - Narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati Kiniksa Pharmaceuticals Ltd|KNSA - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Kiniksa Corp|KNSA - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Kiniksa|KNSA - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi kiniksa.com|KNSA - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Kiniksa Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:KNSA Kiniksa Pharmaceuticals, Ltd.
Kiniksa Pharmaceuticals (KNSA) kompaniyasining antitanachlar patentlari orqali ta'minlangan yallig'lanish kasalliklarini davolashdagi monopoliya maqomi uning daromadlarining bozor qiymatiga bevosita ta'sir ko'rsatadi. 4.90 ning joriy qiymati bozor kapitalizatsiyasining savdo hajmi nisbatini aks ettirib, investorlarning daromadning bir birligi uchun qancha to'lashga tayyorligini ko'rsatadi; narx-savdo ko'paytirgichining tarixi aktivning nufuzi va haddan tashqari yuqori baholash xavflari o'rtasidagi muvozanatni baholash imkonini beradi.
Kiniksa Pharmaceuticals raqobatchilari
argenx - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (biontech.de)|Abivax Corp (ABVX) - Sotuvga nisbatan narx|ADMA Corp - P/S multiplikatori|Narxning sotuvga nisbati PTGX|Immunovant Inc (IMVT) - Narxning daromadga nisbati|Grifols - Bozor kapitallashuvining daromadga nisbati|ADPT (Adaptive Biotech) - P/S multiplikatori|Narxning daromadga nisbati CLDX|P/S multiplikatori AUPH|Kapitalizatsiyaning daromadga nisbati biocryst.com BCRX|Vera Therapeutics - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV - P/S multiplikatori|ABCL: Narxning daromadga nisbati|Tourmaline Bio, Inc. (TRML) - Narxning daromadga nisbati|Sotuvga nisbatan narx precigen.com (PGEN)|PHAR (pharming.com) - P/S multiplikatori|NKTR (Nektar Therapeutics Inc.) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori UPB|ZBIO - Sotuvga nisbatan narx|P/S multiplikatori IMNM (immunome.com)|Gossamer Bio, Inc. - Narxning daromadga nisbati|KalVista Pharmaceuticals, Inc. - P/S multiplikatori|SEPN (Septerna) - Kapitalizatsiya va daromad nisbati|Pieris Corp (PVLA) - Narxning daromadga nisbati|SVRA - Narx/daromad koeffitsiyenti|RIGL (rigel.com) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati ANAB (AnaptysBio, Inc.)|P/S multiplikatori ATXS|enGene Holdings Inc (ENGN) - Narx/daromad multiplikatori|P/S multiplikatori RAPT (RAPT Therapeutics Inc.)|JBIO (Aerovate) - Narxning sotuvga nisbati|ACRS: Kapitalizatsiyaning daromadga nisbati|KYTX - P/S multiplikatori|TLSA: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Cabaletta Bio, Inc|Narxning daromadga nisbati Ventyx Biosciences, Inc|THTX: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati AVTX (Avalo Therapeutics, Inc)|Kapitalizatsiyaning daromadga nisbati Eledon Pharmaceuticals ELDN|Narxning daromadga nisbati Agenus, Inc. AGEN|P/S multiplikatori Climb Bio Inc. CLYM|ZURA - Narxning daromadga nisbati|Narxning sotuvga nisbati ATYR|ADAG (Adagene Inc.) - Kapitalizatsiyaning daromadga nisbati|ImageneBio Inc (IMA) - P/S multiplikatori|Narxning daromadga nisbati Shattuck Therapeutics|Kapitalizatsiyaning daromadga nisbati equilliumbio.com (EQ)|P/S multiplikatori CNTB|Narx/daromad koeffitsiyenti Immunic Therapeutics|P/S multiplikatori ATRA (Atara Biotherapeutics, Inc.)|IFRX - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati X4 Pharmaceuticals, Inc. (XFOR)|ACET (adicetbio.com) - Kapitalizatsiya va daromad nisbati|CELU: P/S multiplikatori|INMB - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Barinthus Biotherapeutics plc|KZR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SABS|AKTX (Akari Therapeutics Plc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Narxning daromadga nisbati|GOVX: Kapitalizatsiyaning daromadga nisbati|edesabiotech.com (EDSA) - Kapitalizatsiyaning daromadga nisbati|IBIO: P/S multiplikatori|CARM - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati XTLB|Kapitalizatsiyaning daromadga nisbati boltbio.com (BOLT)|Narxning daromadga nisbati HCW Biologics Inc (HCWB)|P/S multiplikatori Aptevo Therapeutics, Inc. (APVO)|Narxning daromadga nisbati aimimmuno.com AIM|Bozor kapitallashuvining daromadga nisbati ADTX|GRI Bio Corporation - P/S multiplikatori|XORTX Corp (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (Vyome Holdings Inc.) - Kapitalizatsiyaning daromadga nisbati|revbiosciences.com (REVB) - P/S multiplikatori|INDP (Indaptus Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Scinai Immunotherapeutics Ltd (SCNI)|Narxning daromadga nisbati CalciMedica Inc (CALI)|AFMD (Affimed NV) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ALLK (Allakos Inc.)|P/S multiplikatori HOOKIPA HOOK|IGMS: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ITOS (iTeos)|OCEA: P/S multiplikatori|TCBP (TC BioPharm Ltd) - Narxning daromadga nisbati|THRD (Third Harmonic Bio Inc) - P/S multiplikatori
